Two new cohorts tie pregnancy blood pressure to a woman's long-term heart risk

A hypertensive pregnancy — pre-eclampsia or gestational hypertension — is now firmly established as a marker of raised cardiovascular risk years later. Two population-based cohort studies published this week in BJOG push the idea somewhere more practical: they point to specific moments and measurements after birth where that future risk becomes visible, and potentially actionable [s1][s2].

The six-week window

The first study used English primary and secondary care records linked to cause-specific mortality data from 2000 to 2020 [s1]. It identified 39,934 women aged 15 to 49 at the time of a birth complicated by a hypertensive disorder of pregnancy [s1]. The researchers then looked at blood pressure recorded roughly six weeks postpartum and tracked a validated composite of 12 cardiovascular diseases [s1].

The headline finding concerns a simple reading. Women whose blood pressure was abnormal at six weeks postpartum had a substantially higher risk of later cardiovascular disease than those with normal readings — 10.9% versus 5.4%, an adjusted hazard ratio of 1.96 (95% CI, 1.51–2.54) [s1]. The overall rate of incident cardiovascular events was 109 per 10,000 person-years, and strikingly, 794 of those events (68%) occurred in women younger than 40 [s1]. These are not diseases of old age arriving on schedule; they are landing in women's thirties.

The more uncomfortable finding is about record-keeping. The authors had to exclude 22,100 women — 55.3% of the cohort — because no blood pressure value was recorded at six weeks postpartum at all [s1]. In other words, more than half of women who had just had a hypertensive pregnancy had no documented blood-pressure check at the point where it carries clear prognostic weight. The authors frame the immediate postpartum period as "a crucial window" for preventive care [s1].

Pregnancy history sharpens the prediction

The second study, drawing on Dutch primary care linked to the national perinatal registry and Statistics Netherlands, asked a related question: does knowing a woman's pregnancy history actually improve how well we can predict her future hypertension? [s2] It followed 28,234 women after a first birth at 24 weeks or later between 2007 and 2019, for up to 10 years [s2]. Over that time, 639 developed hypertension, a cumulative 10-year incidence of 3.3% [s2].

The researchers built two prediction models. The first used only sociodemographic and conventional cardiovascular factors and achieved a C-index — a measure of how well a model separates those who will develop hypertension from those who won't — of 0.659 (95% CI, 0.642–0.684) [s2]. Adding pregnancy-related factors lifted that to 0.772 (95% CI, 0.754–0.796) [s2]. The improvement of 0.113 (95% CI, 0.092–0.132) was, the authors report, "mostly driven by the inclusion of hypertensive disorders of pregnancy" [s2]. Net reclassification improved by 0.213 (95% CI, 0.159–0.273) for women who went on to develop hypertension, with essentially no change for those who did not [s2].

Why the two fit together

Read side by side, the studies make a coherent case. The Dutch model shows that pregnancy history — above all a hypertensive disorder of pregnancy — carries real predictive information that standard cardiovascular risk tools miss [s2]. The English cohort shows where that information can be captured and acted on: a single blood-pressure reading at the routine six-week postpartum visit flags women at roughly double the long-term cardiovascular risk [s1].

Both are observational, with the usual caveats. They can show association, not cause, and the English analysis depended on whether a blood pressure happened to be recorded — itself a marker of engagement with care [s1]. The Dutch model was developed in one national dataset and, like any prediction tool, needs external validation before it guides individual decisions [s2].

What it means

The clinical message is unusually concrete for cardiovascular prevention, a field more used to decades-long horizons. A hypertensive pregnancy is a documented early warning, and the weeks right after birth are when that warning is loudest and most measurable. Yet the English data suggest the measurement is frequently not even taken [s1]. The cheap intervention here is not a drug; it is making sure every woman who had a hypertensive pregnancy gets her blood pressure checked and recorded postpartum, and is told what that reading means for the decades ahead.

There is a structural point buried in both studies, too. Routine cardiovascular risk calculators were largely built and validated in older, often male populations, and they tend to score young women as low-risk almost by default. Pregnancy offers a rare, universal stress test of a woman's cardiovascular system in her twenties and thirties, and a hypertensive pregnancy is that test coming back abnormal [s2]. The practical obstacle is less about the science than about handoff: obstetric teams hold the warning signal, but long-term cardiovascular follow-up falls to primary care, and the postpartum visit is where responsibility for that information most easily slips between the two. Closing that gap — a recorded six-week reading, a note in the primary care record, and a clear threshold for follow-up — is low-cost and, on this evidence, overdue [s1][s2].